• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

资源有限情况下TFE3重排肾细胞癌的诊断方法:一例报告

Approach to Diagnosis of TFE3-rearranged Renal Cell Carcinoma in a Limited Resource Setting: A Case Report.

作者信息

Pagarigan Allison Kaye Lombridas, Reyes-Murillo Pamela Delos, Carbonell Dennis Jose Sienes

机构信息

Department of Pathology and Laboratory Medicine, National Kidney and Transplant Institute, East Avenue, Barangay Central, Quezon City, Philippines.

出版信息

J Kidney Cancer VHL. 2024 Aug 24;11(3):40-44. doi: 10.15586/jkcvhl.v11i3.338. eCollection 2024.

DOI:10.15586/jkcvhl.v11i3.338
PMID:39206137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11350386/
Abstract

This report recounts the diagnostic workup of a pediatric female who presented with hematuria secondary to a large renal mass visualized on abdominal imaging. Histologic assessment and subsequent immunohistochemistry studies were performed. Intense, unequivocal immunohistochemical expression of TFE3 and alpha-methylacyl-CoA-racemase with corresponding negativity for carbonic anhydrase IX, along with highly distinctive clinical, radiologic, gross, and microscopic findings confirmed the diagnosis of a renal cell carcinoma with TFE3 gene rearrangement - the first ever reported case in the Philippines. This case highlights the vital role and significant diagnostic impact of reliable, affordable and accessible immunohistochemistry studies in low-resource settings where molecular modalities for evaluating rare diseases are largely unavailable. Recognition of distinctive morphologic, immunohistochemical, and cytogenetic features in childhood and adolescent renal malignancies allows for the timely institution of therapeutic interventions for this aggressive entity.

摘要

本报告叙述了一名儿科女性患者的诊断检查过程,该患者因腹部影像学检查发现巨大肾肿块继发血尿。进行了组织学评估及后续免疫组化研究。TFE3和α-甲基酰基辅酶A消旋酶的免疫组化表达强烈且明确,碳酸酐酶IX呈相应阴性,同时伴有高度独特的临床、放射学、大体和显微镜检查结果,确诊为TFE3基因重排的肾细胞癌——菲律宾首例报告病例。该病例凸显了在资源匮乏地区可靠、经济且可及的免疫组化研究的重要作用和重大诊断意义,在这些地区,评估罕见疾病的分子检测方法基本无法获得。认识儿童及青少年肾恶性肿瘤独特的形态学、免疫组化和细胞遗传学特征,有助于及时对这种侵袭性疾病采取治疗干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/11350386/340312508a18/JKCVHL-11-040-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/11350386/578f88691e98/JKCVHL-11-040-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/11350386/565bca65cfd2/JKCVHL-11-040-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/11350386/10c0b8581366/JKCVHL-11-040-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/11350386/340312508a18/JKCVHL-11-040-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/11350386/578f88691e98/JKCVHL-11-040-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/11350386/565bca65cfd2/JKCVHL-11-040-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/11350386/10c0b8581366/JKCVHL-11-040-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/11350386/340312508a18/JKCVHL-11-040-g004.jpg

相似文献

1
Approach to Diagnosis of TFE3-rearranged Renal Cell Carcinoma in a Limited Resource Setting: A Case Report.资源有限情况下TFE3重排肾细胞癌的诊断方法:一例报告
J Kidney Cancer VHL. 2024 Aug 24;11(3):40-44. doi: 10.15586/jkcvhl.v11i3.338. eCollection 2024.
2
Xp11 translocation renal cell carcinoma and clear cell renal cell carcinoma with TFE3 strong positive immunostaining: morphology, immunohistochemistry, and FISH analysis.Xp11 易位性肾细胞癌和 TFE3 强阳性免疫染色的透明细胞肾细胞癌:形态学、免疫组织化学和 FISH 分析。
Mod Pathol. 2019 Oct;32(10):1521-1535. doi: 10.1038/s41379-019-0283-z. Epub 2019 Jun 7.
3
ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma.TFE3 阳性肾细胞癌中的 ALK 重排:排除 Xp11.2 易位癌的另一种诊断选择。
Pathol Res Pract. 2020 Dec;216(12):153286. doi: 10.1016/j.prp.2020.153286. Epub 2020 Nov 9.
4
Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.Xp11.2 肾细胞癌和肺泡软组织肉瘤中 TFE3 重排的分子细胞遗传学分析:75 例验证和临床经验。
Mod Pathol. 2014 Jan;27(1):113-27. doi: 10.1038/modpathol.2013.83. Epub 2013 Jul 5.
5
TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.TFE3 断裂分离 FISH 检测与 TFE3 或组织蛋白酶 K 免疫组化染色单独检测相比,对 Xp11.2 易位相关性肾细胞癌具有更高的敏感性:扩大形态学谱。
Am J Surg Pathol. 2013 Jun;37(6):804-15. doi: 10.1097/PAS.0b013e31827e17cb.
6
Immunohistochemical panel for differentiating renal cell carcinoma with clear and papillary features.用于鉴别具有透明和乳头状特征的肾细胞癌的免疫组织化学检测组合
J Microsc Ultrastruct. 2015 Apr-Jun;3(2):68-74. doi: 10.1016/j.jmau.2015.01.003. Epub 2015 Feb 3.
7
The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray.女性生殖道透明细胞癌、透明细胞肾细胞癌和易位相关性肾细胞癌的鉴别:应用组织微阵列的免疫组织化学研究。
Int J Gynecol Pathol. 2011 Sep;30(5):425-30. doi: 10.1097/PGP.0b013e318214dd4f.
8
PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.PSF/SFPQ 是 TFE3 重排相关血管周上皮样细胞瘤(PEComa)和黑色素性 Xp11 易位肾细胞癌中非常常见的基因融合伙伴:提示分类为独特实体的临床病理、免疫组织化学和分子特征。
Am J Surg Pathol. 2015 Sep;39(9):1181-96. doi: 10.1097/PAS.0000000000000502.
9
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.在肾脏肿瘤咨询服务中使用 TFE3 断裂 FISH 检测。
Am J Surg Pathol. 2013 Aug;37(8):1150-63. doi: 10.1097/PAS.0b013e31828a69ae.
10
RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations.Xp11 易位相关性癌症的 RNA 测序揭示了新的基因融合和独特的临床病理相关性。
Mod Pathol. 2018 Sep;31(9):1346-1360. doi: 10.1038/s41379-018-0051-5. Epub 2018 Apr 30.

本文引用的文献

1
Case Reports of TFE3-Rearranged Renal Cell Carcinoma: FDG-PET Uptake Might Help Diagnosis.TFE3 重排性肾细胞癌病例报告:氟代脱氧葡萄糖正电子发射断层显像摄取情况可能有助于诊断。
J Kidney Cancer VHL. 2023 Sep 27;10(3):61-68. doi: 10.15586/jkcvhl.v10i3.266. eCollection 2023.
2
TFE3 gene rearrangement and protein expression contribute to a poor prognosis of renal cell carcinoma.TFE3基因重排和蛋白表达导致肾细胞癌预后不良。
Heliyon. 2023 May 6;9(5):e16076. doi: 10.1016/j.heliyon.2023.e16076. eCollection 2023 May.
3
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms.
TFE3 和 TFEB 重排的肾细胞癌:一个免疫组织化学panel 来与常见的肾细胞肿瘤相鉴别。
Virchows Arch. 2022 Dec;481(6):877-891. doi: 10.1007/s00428-022-03380-x. Epub 2022 Aug 18.
4
Targeted therapy in Xp11 translocation renal cell carcinoma.Xp11 易位性肾细胞癌的靶向治疗。
Klin Onkol. 2021 Spring;34(2):137-140. doi: 10.48095/ccko2021137.
5
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.现有世卫组织实体的新发展和不断发展的分子概念:泌尿生殖系统病理学学会 (GUPS) 关于肾肿瘤的更新。
Mod Pathol. 2021 Jul;34(7):1392-1424. doi: 10.1038/s41379-021-00779-w. Epub 2021 Mar 4.
6
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey.TFE3 基因重排相关性肾细胞癌的诊断方法:一项多机构国际调查。
J Clin Pathol. 2021 May;74(5):291-299. doi: 10.1136/jclinpath-2020-207372. Epub 2021 Jan 29.
7
Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study.免疫组织化学法检测 TFE3 在 TFE3 重排肿瘤的诊断中特异性和敏感性均不足:一项 2 家实验室的对比研究。
Hum Pathol. 2019 May;87:65-74. doi: 10.1016/j.humpath.2019.02.008. Epub 2019 Mar 6.